Track the USANA HEALTH SCIENCES, INC. share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was reported on 16 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: BRENT LOWELL NEIDIG. All data is accessible without an account.
Analysts rate USANA HEALTH SCIENCES, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
USANA Health Sciences, Inc. 是一家专门生产保健产品和营养补充品的公司。该公司在纳斯达克上市,股票代码为 USNA。